|
Volumn 309, Issue 5740, 2005, Pages 1481-
|
Vioxx verdict: Too little or too much science?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
ROFECOXIB;
VALDECOXIB;
LACTONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SULFONE;
SCIENCE IN GENERAL;
ADULT;
ARTHRITIS;
AUTOPSY;
BLOOD CLOT;
CASE REPORT;
DEATH;
DEATH CERTIFICATE;
DRUG INDUSTRY;
DRUG SURVEILLANCE PROGRAM;
HEART ARRHYTHMIA;
HEART INFARCTION;
HUMAN;
LAW SUIT;
MALE;
PRIORITY JOURNAL;
SHORT SURVEY;
STOMACH HEMORRHAGE;
STROKE;
ARTICLE;
LEGAL ASPECT;
MIDDLE AGED;
CYCLOOXYGENASE INHIBITORS;
DRUG INDUSTRY;
HUMANS;
LACTONES;
MALE;
MIDDLE AGED;
SULFONES;
|
EID: 24644439201
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.309.5740.1481 Document Type: Short Survey |
Times cited : (5)
|
References (0)
|